, Gilbert Habib 12, 13 , and Bogdan A. Popescu A total of 159 patients who underwent simultaneous evaluation of echo estimates of LVFP and invasive measurements of LV end-diastolic pressure (LVEDP) were enrolled at nine EACVI centres. Thirty-nine (25%) patients had a reduced LV ejection fraction (<50%), 77 (64%) were in NYHA > _ II, and 85 (53%) had coronary artery disease. Sixty-four (40%) patients had elevated LVEDP (> _15 mmHg). Taken individually, all echocardiographic Doppler estimates of LVFP (E/A, E/e 0 , left atrial volume, tricuspid regurgitation jet velocity) were marginally correlated with LVEDP. By using the 2016 recommendations, 65% of patients with normal non-invasive estimate of LVFP had normal LVEDP, while 79% of those with elevated non-invasive LVFP had elevated invasive LVEDP. By using 2009 recommendations, 68% of the patients with normal non-invasive LVFP had normal LVEDP, while 55% of those with elevated non-invasive LVFP had elevated LVEDP. The 2016 recommendations (sensitivity 75%, specificity 74%, positive predictive value 39%, negative predictive value 93%, AUC 0.78) identified slightly better patients with elevated invasive LVEDP (> _ 15 mmHg) as compared with the 2009 recommendations (sensitivity 43%, specificity 75%, positive predictive value 49%, negative predictive value 71%, AUC 0.68). 
Introduction
Elevated left ventricular filling pressure (LVFP) results in shortness of breath, which is both a major symptom and a prognostic predictor of heart failure. 1 Accordingly, non-invasive estimation of LVFP is an important goal of echocardiographic examination. Mitral inflow, tissue Doppler annular velocities, tricuspid regurgitation (TR) velocity, and left atrial volume (LAV) are the cornerstones of diastolic function evaluation. The E/e 0 ratio is probably the most extensively used parameter for estimation of LVFP in daily practice, and its prognostic value is widely recognized. [2] [3] [4] However, the fact that the various parameters used are subject to fundamental limitations and reflect different physiological aspects of diastole has led to substantial ambiguity in the diagnosis of LV diastolic dysfunction. Recognition of this shortcoming has led to a first attempt by the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE) in 2009 to combine these parameters into a series of algorithms. 5 To examine and validate the accuracy and clinical utility of individual echocardiographic parameters and of these algorithms, the EACVI Research committee launched in 2014 the Euro-Filling Study, a large multicentre prospective project with simultaneous assessment of invasive measurements and non-invasive estimates of LVFP. 6 In the meantime, the EACVI and the ASE published in 2016 the updated recommendations for assessment of diastolic function, suggesting a simplified approach. 7 However, these updated algorithms, based on expert consensus, have not been validated yet.
The present report examined non-invasive estimates of LV filling pressure against the simultaneous measurement of invasive LVFP. 6 In addition to the pre-specified objectives of the Euro-Filling study we evaluated the diagnostic accuracy of the 2016 EACVI/ASE grading algorithm for predicting invasively measured LVFP.
Methods

Study population and protocol
The Euro-Filling is a multicentre study involving nine reference centres across Europe, able to recruit consecutive adult patients of both genders undergoing clinically indicated coronary angiography due to ascertained or suspected coronary artery disease. Each centre was requested to recruit patients with and without heart failure for cardiac catheterization and simultaneous echocardiographic examination to assess LV diastolic function. Prior to the inclusion, we excluded all patients with acute coronary syndrome, more than mild valvular heart disease, valvular prosthesis, mitral annulus calcification, previous myocardial infarction involving basal septum and/or basal lateral wall, atrial fibrillation and severe arrhythmias precluding Doppler analysis, left bundle branch block, any kind of pacemaker, hypertrophic cardiomyopathy, pericardial disease, inadequate echocardiographic imaging or any administration of diuretics or vasodilators (nitrates) within the day prior the hemodynamic evaluation. 6 The institutional review board of each hospital approved the study protocol and all patients gave written informed consent.
Echocardiography
Echocardiography was performed using commercially available ultrasound systems (GE Healthcare systems). Patients underwent a preliminary complete echocardiographic Doppler examination the same day but before (within 1/2 h) the invasive and non-invasive assessment of LVFP.
This echocardiographic study included standard measurements of LV and right ventricular chambers, left atrial volume, LV end-diastolic and endsystolic volumes (biplane Simpson method) and ejection fraction (EF). 8 Left atrial volume was indexed for body surface area (LAVi). LV mass was calculated according to recommendations and indexed for body surface area. All echocardiographic and Doppler data were obtained in digital format and stored on optical disks for central off-line analysis in an echocardiographic core laboratory (Liège, Belgium). All patients also underwent a targeted echocardiographic exam simultaneously with the invasive measurement of LVFP by left heart on the catheterization table immediately before coronary angiography. Pulsed wave standard Doppler mitral inflow interrogation was performed in the apical 4-chamber view and was used to measure transmitral E and A peak velocities and the E/A ratio. In the same apical 4-chamber view, e 0 velocity was measured at the septal and lateral sides of the mitral annulus and averaged, and the E/e 0 ratio was then calculated. The tricuspid regurgitation (TR) jet peak velocity was also measured. LV diastolic function and LVFP were graded according to mitral valve E/A ratio, E velocity, septal or lateral e 0 , TR velocity (if TR was present), LAVi, and average E/e 0 . Based on the 2016 recommendations, 7 a two-step approach was used by dividing patients into 2 groups: those with reduced LVEF (<50%) and those with preserved LVEF (> _50%) ( Figure 1 ). In patients with preserved LVEF and non-structural heart disease (LV hypertrophy, ischaemic cardiomyopathy), a first-step decision tree allowed grading diastolic function and LVFP as normal, indeterminate, or abnormal ( Figure 1A) . Patients with preserved LVEF and diastolic dysfunction or with structural heart disease, and those with reduced LVEF were then graded using a second-step approach according to transmitral valve E/A ratio and E velocity ( Figure 1B) . LVFP was also estimated according to 2009 recommendations, 5 based on either septal e 0 or lateral e 0 < 10 m/s, transmitral E/A ratio, E velocity deceleration time and average E/e 0 ratio. Reproducibility of Doppler and LA size measurements has been published previously.
9,10
Left ventricular end-diastolic pressure (LVEDP)
LV pressures were recorded prior to coronary angiography (i.e. before any contrast injection). A 6-French pigtail catheter was balanced to the zero level at the mid-axillary line. The catheter was then placed in the LV chamber via the femoral or brachial artery and calibrated against the pressure measured simultaneously with the fluid-filled lumen at end diastole. LV pressure was recorded at end expiration for three consecutive cardiac cycles and digitized. LV end-diastolic pressure (LVEDP) was measured as previously described. 6 All parameters were averaged over three consecutive cardiac cycles. Elevated LVFP was defined as LVEDP > _15 mmHg. Measurements were performed in the cath core laboratory (Oslo, Norway) blinded for the echocardiographic data.
Statistical analysis
Continuous data are expressed as mean ± standard deviation. Categorical data are presented as an absolute number and percentages.
Comparison of baseline characteristics between the two groups was performed using analysis of variance or v 2 test as appropriate. Linear regression analysis was performed to determine the correlation between parameters. Multiple linear regression models were generated to assess the independent associations between echocardiographic surrogates of LVFP with invasive LVEDP. To assess the diagnostic ability of the echocardiographic parameters, we performed receiver-operating characteristic (ROC) analysis. All statistical analysis was carried out using commercial software (STATISTICA 12). A P-value of < 0.05 was considered statistically significant.
Results
The nine centres involved (Bucharest, Liège, Leipzig, Lisbon, Marseille, Naples, Oslo, Rennes, and Wien) recruited a total number of 159 patients.
Characteristics of the study population
Characteristics of the study population are summarized in Table 1 . A history of myocardial infarction was noted in 29 (18%) patients, 94 (59%) had arterial hypertension, 42 (26%) were diabetic, 53% had coronary artery disease (> _50% stenosis in > _1 vessel), and 23% had multivessel disease. Cardiac medications included angiotensin converting enzyme (ACE) inhibitors in 109 patients, diuretics (withdrawn at least the day prior the hemodynamic evaluation) in 38, and betablockers in 112. A total of 39 (25%) patients had a reduced LVEF (<50%). Patients with reduced LVEF had more often diabetes and were more frequently dyspnoeic compared with patients with preserved LVEF. ACE-inhibitors and diuretics were more frequently used in patients with reduced LVEF. Patients with LVEF <50% had larger LV and LA volumes, a higher LV mass, and more often impaired parameters of LV diastolic function (E/A ratio, e 0 velocity, E/e 0 ratio, TR velocity). Tricuspid regurgitation was recorded in 63 patients. These patients also had higher invasive LVEDP and 23 (58%) of them had LVEDP > _ 15 mmHg.
Correlates of LVEDP
The correlations of invasive LVEDP with Doppler variables, and stratified according to LVEF, are shown in Table 2 . Among patients with LVEF <50%, there were significant correlations between LVEDP and mitral E velocity (r = 0.57), E/A ratio (r = 0.63), E/e 0 septal (r = 0.39), E/e 0 average (r = 0.31), and LAVi (r = 0.36). In patients with LVEF > _50%, LVEDP was correlated with transmitral E velocity (r = 0.27), E/A ratio (r = 0.23), and E/e 0 lateral (r = 0.20). E/e 0 average (r = 0.17) also tended to correlate with LVEDP in these patients (P = 0.07). Intriguingly, LAVi was not correlated with LVEDP in patients with LVEF > _50%. To eliminate potential collinearity effect, we first combined E velocity, E/A ratio, e 0 velocity, and E/e 0 ratio into a multiple regression model and both E/A and E/e 0 emerged as correlated to LVEDP (P < 0.0001, r 2 = 0.24). In a second multivariable step model, after adjustment for TR velocity and LVEF, E/A ratio (P = 0.02), average E/e 0 (P = 0.032), and LAVi (P = 0.048) (r 2 = 0.26, P < 0.0001)
were associated with LVEDP. In patients with LVEF > _ 50%, E/e 0 lateral (r 2 = 0.16, P = 0.0025) or E/e 0 average (r 2 = 0.16, P = 0.003) emerged as independent correlates of invasive LVEDP. In those with LVEF < 50%, E/A ratio was the only independent parameter correlated with LVEDP (r 2 = 0.38, P = 0.029).
Echo estimates of LV end-diastolic pressure Table 2 summarizes the associations between echo Doppler estimates of diastolic function and invasive LVEDP. No significant difference was observed in these parameters according to LVEF in patients with LVEDP <15 mmHg. Conversely, most of them reached pathological cut-off point values in cases of increased LVEDP (> _15 mmHg) ( Table 3) . By using the 2016 recommendations, LVFP was estimated as normal in 108 (68%) patients, elevated in 24 (15%), and undetermined in 27 (17%) ( Table 4) . About 2/3 of patients with normal noninvasive estimate of LVFP had normal invasive LVEDP (<15 mmHg), while 79% of those with elevated non-invasive LVFP had elevated invasive LVEDP (> _15 mmHg). About 26% of those with undetermined non-invasive LVFP had elevated invasive LVEDP (> _15 mmHg). Two thirds of those with abnormal non-invasive LVFP had elevated invasive LVEDP (> _15 mmHg). By using 2009 recommendations, LVFP was normal in 103 (65%) patients and elevated in 56 (35%) ( Table 5) .
Two thirds of those with normal non-invasive LVFP had normal invasive LVEDP (<15 mmHg), while 50% of those with elevated noninvasive LVFP had elevated invasive LVEDP (> _15 mmHg). The 2016 recommendations (sensitivity 75%, specificity 74%, positive predictive value 39%, negative predictive value 93%, AUC 0.78) identified slightly better patients with elevated invasive LVEDP (> _ 15 mmHg) as compared with the 2009 recommendations (sensitivity 43%, specificity 75%, positive predictive value 49%, negative predictive value 71%, AUC 0.68) (Figures 2 and 3) . 
Discussion
In this multicentre study, we prospectively evaluated the diagnostic value of the 2016 ASE/EACVI Recommendations for LVFP assessment. To the best of our knowledge, the Euro-Filling study recruited the largest cohort of patients with simultaneous invasive and noninvasive evaluation of LVFP. 26 and it appears to be dependent on the clinical context, with lower sensitivity in patients with normal LVFP. In the Euro-Filling study, where 40% of the patients had elevated measured LVEDP, the positive and negative predictive values of average E/e 0 > _14 to detect abnormal invasive LVFP were modest (56% and 62%, respectively).
Algorithms for evaluating LVFP
According to 2016 EACVI/ASE recommendations, 7 echocardiographic measurements of LVFP should be combined into algorithms to minimize the limited accuracy of individual measurements. However, neither the 2009 nor the 2016 recommendations have been validated to date. In the present study, application of the 2016 recommended algorithm, created to define the probability of LV diastolic function, identified patients with elevated LVFP with greater accuracy than the approach proposed in 2009. The 2016 algorithm likely exploits the major advantage offered by the two-step decision tree, with elimination of patients with ambiguous categorization such as 'indeterminate or cannot determine' (27/159 patients, 17%). Less than one fifth of the patients with normal invasive LVEDP had abnormal non-invasive LVFP by echocardiography. Most of them had reduced LVEF (<50%). About 26% of the patients in the 'indeterminate' category had elevated invasive LVEDP. The majority of them had preserved LVEF (> _50%). Interestingly, both algorithms have similar power to identify patients with normal LVFP as a surrogate of normal invasive LVEDP. 
Strengths of the study
To the best of our knowledge, the Euro-Filling is the largest study (n = 159) assessing simultaneously recorded echo Doppler estimates of LVFP and invasive LVEDP by cardiac catheterization. Most of the previous single-centre studies attempted to validate E/e 0 ratio against invasively determined pulmonary capillary wedge pressure (i.e. an indirect estimate of LVFP), on smaller population sample sizes.
27-33
Only Ommen et al. 34 compared E/e 0 ratio with mean LV diastolic pressure in 100 patients with heart failure. Despite involving nine different European centres, the measurements of the Euro-Filling data were centralized in two separate core laboratories (Liege for echo Doppler indexes and Oslo for invasive parameters) and they were unaware of the measurements from the other laboratory. The existence of core laboratories is strongly encouraged by the EACVI since it is fundamental to ensure quality control and to limit the variability of measurements in clinical studies. 35 This choice can be considered important also to reduce the possible inhomogeneity of the imaging recording among the participating centres. 36 However, the determination of PCWP implies the performance of a right catheterization, non-sustainable by the ethical point of view in patients with suspected or ascertained coronary artery disease. Our choice privileged LVEDP on the grounds of its important pathophysiological meaning for identifying patients at increased risk for developing clinical symptoms of heart failure and its recognized prognostic value in patients with coronary artery disease. 37, 38 Another limitation corresponds to the relatively low prevalence of TR (39.6%), which is however consistent with a similar prevalence of abnormally increased LVEDP (40.2%). We also did not routinely use contrast to improve the feasibility of TR jet recordings and this may partly account for a low number of TR. Moreover, we did not analyse the incremental power of each echocardiographic parameter to establish new algorithms and patients with reduced LVEF represented only 25% of the population. The use of stress diastology in selected cases might have possibly improved the diagnostic accuracy of the 2016 algorithm but this was not the objective of the current study. Finally, the measurement of invasive LV pressure was performed with fluid-filled catheters, which although representative of common clinical practice, may not be as accurate as measurements performed using Millar catheters.
Conclusion
The present Euro-Filling study demonstrates that the new 2016 recommendations for assessing LVFP non-invasively are fairly reliable and clinically useful, as well as superior to the 2009 recommendations in estimating the level of invasively determined LVEDP. This applies in particular to patients with reduced EF, a delicate setting in which the novel recommendations can make the difference whereas the recognition of elevated LVEDP remains suboptimal in patients with normal EF. Although discordant findings to invasive measurements were significantly reduced in the group of patients with abnormal noninvasive LVFP estimates, low sensitivity and (negative) predictive value of normal LVFP estimates remain a problem also with the 2016 recommendations. Therefore, there is a particular need to search for improving the diagnostic accuracy of echocardiography in this patient group. Further work is also needed to evaluate the prognostic impact of these new decisional algorithms. Echo estimates of LVFP
